Neurodegenerative Disease Diagnostic

About AGED Diagnostics

Founded in 2018, AGED Diagnostics is a private, pre-revenue company operating in the high-growth diagnostics sector, specifically targeting the aging population. The company's core strategy involves integrating multi-omics biomarker discovery with proprietary artificial intelligence and machine learning algorithms to create non-invasive, blood-based diagnostic tests. This approach aims to address the critical unmet need for early, accessible, and cost-effective detection of complex age-related diseases, positioning the company at the intersection of diagnostics, geroscience, and digital health. While still in the development stage, AGED is building a pipeline of diagnostic programs with the goal of improving patient outcomes and reducing long-term healthcare costs.

Therapeutic Areas

Other Alzheimer's Disease & Related Dementias Drugs